- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Vemurafenib and Trientine
Total 272767 results
-
Novartis PharmaceuticalsCompleted
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Genentech, Inc.Terminated
-
Shanghai Kechow Pharma, Inc.Recruiting
-
HonorHealth Research InstituteBayer; Genentech, Inc.Recruiting
-
Hoffmann-La RocheCompletedNeoplasmsFrance, Hungary, Spain, Korea, Republic of, United Kingdom, United States, Croatia, Greece, Portugal, Germany, Bosnia and Herzegovina, Belgium, South Africa, Israel, Romania, New Zealand, Italy, Canada, Netherlands, Egypt, Russian... and more
-
University of UtahWithdrawn
-
Fondazione Melanoma OnlusRoche S.p.aTerminatedMelanoma | Melanoma (Skin) | Melanoma StageItaly
-
PlexxikonRoche Pharma AGCompletedColorectal Carcinoma | Malignant MelanomaUnited States, Australia
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruiting
-
Shanghai Kechow Pharma, Inc.Recruiting
-
UNICANCERHoffmann-La Roche; National Cancer Institute, France; Fondation ARCActive, not recruitingSolid Tumors | Hematologic Cancers | Metastatic CancersFrance
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Northwestern University; Northwell Health; Dana-Farber... and other collaboratorsActive, not recruitingHairy Cell LeukemiaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Melissa Burgess, MDGenentech, Inc.TerminatedActive Melanoma Brain MetastasesUnited States
-
Yale UniversityGenentech, Inc.Completed
-
Hoffmann-La RocheWithdrawn
-
Ain Shams UniversityUnknownBeta Thalassemia MajorEgypt
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Hoffmann-La RocheCompletedNeoplasmsUnited Kingdom, Israel, United States, Russian Federation, Australia, Greece, Turkey
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruiting
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingGlioma | Melanoma | Carcinoma, Non-Small-Cell Lung | Multiple Myeloma | Colorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Thyroid Cancer, Papillary | Thyroid Carcinoma, Anaplastic | Laryngeal Neoplasms | Erdheim-Chester Disease | Haematological MalignancyUnited Kingdom
-
Shanghai Kechow Pharma, Inc.Recruiting
-
Shanghai Kechow Pharma, Inc.Not yet recruitingColorectal Cancer Metastatic
-
ApoPharmaCompleted
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Georgetown UniversityGenentech, Inc.; Melanoma Research AllianceTerminatedMelanomaUnited States
-
Genentech, Inc.Blueprint Medicines CorporationRecruitingNon-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Hoffmann-La RocheWithdrawn
-
Memorial Sloan Kettering Cancer CenterCompletedThyroid Cancer, Papillary | Thyroid Cancer, Follicular | Thyroid Carcinoma | Thyroid Cancer | Thyroid Cancer (Follicular Cell) | BRAF V600E Mutation PositiveUnited States
-
Memorial Sloan Kettering Cancer CenterYale University; Dana-Farber Cancer InstituteActive, not recruitingLeukemia | Leukemia, Hairy Cell | Hairy Cell LeukemiaUnited States
-
Yana NajjarMerck Sharp & Dohme LLCTerminatedMelanomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingVemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive CraniopharyngiomaBRAF V600E Mutation Present | Papillary CraniopharyngiomaUnited States
-
University of California, San FranciscoGenentech, Inc.Active, not recruitingPediatric Recurrent/Refractory BRAFV600E-mutant GliomasUnited States, Canada
-
University Hospital, EssenCompleted
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
PfizerCompleted
-
Massachusetts General HospitalTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Hoffmann-La RocheCompletedNeoplasmsUnited States, France, Italy, Netherlands
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; ExelixisActive, not recruitingMelanoma | Skin CancerUnited States
-
Hoffmann-La RocheCompleted
-
University of ArizonaTerminatedMalignant MelanomaUnited States